- Original Articles Hemato-oncology Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer
- Chan-Young Ock, Shin-Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Doo Hyun Chung, Dae Seog Heo
- Korean J Intern Med. 2019;34(5):1116-1124.